Multiple Sclerosis Discovery Forum

Inspiring Connections

Sort By: Most Recent Article / Most Recent Comments / Most Comments

News Briefs | 16 Nov 2014

FDA Approves Alemtuzumab for MS

Reversing a decision made in 2013, the FDA approved Lemtrada (Genzyme/Sanofi) in a restricted program for relapsing forms of MS

Carol Cruzan Morton

Late Fridays are often reserved for releasing bad news, but at 9 pm ET on November 14...

Drug Development

News Synthesis | 14 Nov 2014

DMT Discontinuation Review Stirs MS Research Community

The U.S. Agency for Healthcare Research and Quality (AHRQ) recently released a draft review on the evidence on discontinuation of disease-modifying therapies. Shocked by the apparent lack of expertise in the first draft, MS researchers and advocacy groups sent in a wave of comments chastising the AHRQ for the perceived shoddiness of the report.

Cynthia McKelvey

A draft review of the evidence surrounding discontinuation of disease-modifying therapies has sparked...

Clinical Research, Methods

News Briefs | 11 Nov 2014

MS Research Roundup: November 11, 2014

Repurposing Older, Cheaper Drugs in Britain; Plovamer Acetate Pulled From Pipeline; Singing for a (Healthier) Supper; Seeking Earlier MS Diagnosis

Cynthia McKelvey and Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, People

Blogs | 7 Nov 2014

Invitation to Share Your Thoughts on a New MS Research Resource

iConquerMS™ will connect researchers with a 20,000-person MS cohort

Hollie Schmidt

An important new research resource will be launching soon, and Accelerated Cure Project would like to hear how you might use it.

Clinical Research, People

News Briefs | 5 Nov 2014

MS Research Roundup: November 5, 2014

One Clinic’s Tecfidera PML Guidelines; Innovation Award for MS Genomics; Journalism Prize to MSDF Contributor

Cynthia McKelvey and Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, People

New Findings | 4 Nov 2014

MS Genetics: The Outer Limits

In a mashup of data sets and new genome-mapping tools, a study finds that most of the inherited risk for autoimmune disease discovered so far comes from mysterious noncoding regions and mostly affects immune cells

Carol Cruzan Morton

Since 2007, ever larger and more powerful genome-wide association studies have found...

Laboratory Research

Blogs | 4 Nov 2014

“No great discovery was ever made without a bold guess,” Sir Isaac Newton

There’s an urgent need to find answers for the more than one million people living with progressive MS

Professor Alan Thompson

As researchers, we know how exciting it is when this axiom comes true, especially when...

Clinical Research, Laboratory Research

New Findings | 29 Oct 2014

New iPad App Tracks MS Patient Course

Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s disease course over time and compare it to a core data set of other MS patients. The tool is currently in beta-testing at UCSF.

Cynthia McKelvey

Pierre-Antoine Gourraud, Ph.D., of the University of California, San Francisco, and I huddled around his iPad and...

Clinical Research, People

News Briefs | 28 Oct 2014

MS Research Roundup: October 28, 2014

Rare Brain Disease Death Reported for Dimethyl Fumarate; Using Arms and Legs After Spinal Cord Injury; How to Sell Bogus Drugs

Cynthia McKelvey

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, People

News Briefs | 22 Oct 2014

MS Research Roundup: October 22, 2014

A Better CRISPR Mouse; Number Needed to Treat; Ann Romney to Raise $50M for Neuroscience Research

Carol Cruzan Morton

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research